Is CPRX A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful...
Catalyst Pharmaceuticals Inc. (CPRX)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 10,000,000 | $46,100 | 1.05% | |
| 2. | Royce & Associates Chuck Royce | 3,249,650 | $14,981 | +36% | 0.1% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 896,592 | $4,133 | +24% | 0.01% |
| 4. | AQR Capital Management Cliff Asness | 723,653 | $3,336 | -28% | 0% |
| 5. | Millennium Management Israel Englander | 612,010 | $2,821 | +41% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.99 | 7,000 | Director | 560,376 | 2020-09-30 | Filing | |
| $2.97 | 15,000 | Officer, Director | 4,787,693 | 2020-09-30 | Filing | |
| $4.70 | 10,000 | Director | 553,376 | 2019-10-11 | Filing | |
| $4.89 | 10,000 | Officer, Director | 4,772,693 | 2019-10-03 | Filing | |
| $3.23 | 25,000 | Officer, Director | 4,762,693 | 2019-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.45 | 3,668 | Officer | 10,998 | 2020-12-22 | Filing | |
| $4.82 | 150,000 | Officer | 0 | 2019-12-05 | Filing | |
| $4.66 | 100,000 | Officer | 0 | 2019-11-27 | Filing | |
| $4.50 | 100,000 | Officer | 0 | 2019-11-21 | Filing | |
| $3.34 | 22,800 | Officer | 74,131 | 2015-10-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 195,001 | $898,955 | 0% | |
| 2. | 29,546 | $136,207 | 0% | |
| 3. | 8,933,983 | $41,186 | 0% | |
| 4. | 8,274,686 | $38,147 | 0% | |
| 5. | 5,586,295 | $25,753 | 0% |
News See All
Hedge Funds Are Crazy About Catalyst Pharmaceuticals, Inc. (CPRX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 823 13F...
5 Midcap Magic Formula Stocks For Total Return
To keep myself sharp and my skills honed, I routinely go to my library of investment books and re-read classics that have had an impact on me. This week I did a complete re-read of Joel Greenblatt...
Did Hedge Funds Make The Right Call On Catalyst Pharmaceuticals, Inc. (CPRX) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings...
Hedge Funds Have Never Been This Bullish On Catalyst Pharmaceuticals, Inc. (CPRX)
In this article you are going to find out whether hedge funds think Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a good investment right now. We like to check what the smart money thinks first before...
Is Catalyst Pharmaceuticals, Inc. (CPRX) A Good Stock To Buy?
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition...
Here is What Hedge Funds Think About Catalyst Pharmaceuticals, Inc. (CPRX)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this...
Should You Buy Catalyst Pharmaceuticals, Inc. (CPRX)?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider...
Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now
There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals that also pay substantial dividends, to small...
13G Filing: Great Point Partners and Catalyst Pharmaceuticals Inc. (CPRX)
GEF-SMA, L.P. (“GEF-SMA”) is the record owner of 1,536,840 shares (the “GEF-SMA Shares”). Great Point is the investment manager with respect to the GEF-SMA Shares, and by virtue of such status...
Billionaire Hedge Funds
